CEO to Review Initiatives in the Treatment of Respiratory Disorders and Provide Pipeline Update RespireRx Announces Ticker Symbol Change Glen Rock, N.J., Jan. 11, 2016/Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC QB: RSPI as of January 11, 2016; previously OTC QB: CORX) (“RespireRx” or the “Company”), a leader in developing drugs for respiratory disorders, particularly sleep…
Cortex CEO James S. J. Manuso, Ph.D. to Present Glen Rock, N.J., October 19, 2015/Globe Newswire – Cortex Pharmaceuticals, Inc. (OTC: CORX) (“Cortex” or the “Company”), a leader in developing drugs for respiratory disorders, particularly obstructive and central sleep apneas and drug-induced respiratory depression, announces that it will be presenting at the 14th Annual BIO…
James S. J. Manuso, Ph.D., New Cortex CEO, to Present GLEN ROCK, NJ — September 8, 2015/Globe Newswire – Cortex Pharmaceuticals, Inc. (OTC: CORX) (“Cortex” or the “Company”), a leader in developing drugs for respiratory disorders, particularly obstructive sleep and central apneas and drug-induced respiratory depression, announces that it will be presenting at the Rodman &…
Dr. Arnold S. Lippa, Ph.D., to Continue as Executive Chairman of the Board of Directors and Chief Scientific Officer GLEN ROCK, NJ — (Marketwired – Aug 19, 2015) – Cortex Pharmaceuticals, Inc. (OTCQB: CORX) (“Cortex” or the “Company”), a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today announced…